Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose

This study aimed to determine the anti-S (receptor binding protein) RBD IgG antibody titers formed against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and the neutralizing antibody inhibition percentages (nAb IH%) in blood samples taken after two doses of inactive or mRNA-based vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gareayaghi, Nesrin, Demirci, Mehmet, Ozbey, Dogukan, Dasdemir, Ferhat, Dinc, Harika Oyku, Balkan, Ilker Inanc, Saribas, Suat, Saltoglu, Neşe, Kocazeybek, Bekir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609633/
https://www.ncbi.nlm.nih.gov/pubmed/36298537
http://dx.doi.org/10.3390/vaccines10101672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609633/
https://www.ncbi.nlm.nih.gov/pubmed/36298537
http://dx.doi.org/10.3390/vaccines10101672

Ejemplares similares